APP and Alzheimer disease: Since it is well-known that neuronal degeneration and loss is widely considered as the main contributors to cognitive impairment in AD [32, 33], to assess whether tan IIA can attenuate neuronal loss, we measured the change in the number of NeuN-positive neurons in the brain of APP/PS1 mice.